BIO 2003 Preliminary Daybook

The world's largest biotechnology convention kicks off June 21-22 with a free two-day HealthFest on the National Mall that will bring home the impact of biotechnology on our lives through more than 100 exhibits. Below is a quick guide to just a few of BIO 2003 events which you may find as "news and background opportunities." More details on specific events can be found on the BIO 2003 programs at www.bio.org. Included are press events, press conferences, lecture series, highlighted sessions, plenary speeches and a quick guide to sessions by theme including science, biodefense, bioethics, business/finance, drug discovery, environmental issues, health and global health policy, industrial and environmental biotechnology and bioethics issues.

Day-by-Day Schedule

All events are at the Washington, D.C., Convention Center unless otherwise noted.

HealthFest 2003 (Continues on Sunday, June 22)
National Mall between 3rd and 4th streets
10:00 a.m. to 3:00 p.m.
This free, interactive event will provide a hands-on biotechnology experience to people of all ages. HealthFest features more than 100 educational exhibits staffed by patient advocacy groups, volunteer health organizations, hospitals, research institutions, biotechnology and biopharmaceutical companies and other health-related organizations.

Special interactive exhibits at Healthfest 2003 include:

• NASA's International Space Station Trailer Exhibit. Within the trailer are video presentations that tell the story of space exploration and offer a glimpse into what it's like to live and work in this international orbiting laboratory, as well as exhibits that showcase the space station's habitation and laboratory modules. HealthFest attendees will also have the opportunity to meet two NASA astronauts.
• The Triple Threat Foundation. NBA player Jerry Stackhouse will be on hand with the Triple Threat Foundation, giving attendees a chance to face off against the Washington Wizards all-star on a specially built court. The Triple Threat Foundation, founded by Stackhouse, educates young people about diabetes and promotes health living as a means of disease prevention.
• Mobile Bioscience Educational Laboratories. Outfitted with state-of-the-art equipment, four mobile bioscience laboratories will expose visitors to "real life" bioscience experiences.
• "Hip Hop Aerobics" and "Cyked" yoga cycling sessions. Crunch Fitness Clubs will host these sessions.
• NikeGO. This program, designed by Nike for children ages nine to 15, helps children discover the joy of movement and the fun of physical activity.
• Cooking demonstrations. The Food Network's "Cooking Thin" host, Kathleen Daelemans, will host a healthy cooking clinic at Healthfest.

Global Biotechnology Forum
Room 146 B/C
9:00 a.m. to 11:30 a.m.
Global business, policy and political leaders will discuss initiatives to foster industry growth and meet future health needs in both industrialized nations and the developing world. The event features two keynote presentations and a moderated roundtable discussion. Panel includes: Lord Sainsbury of Turville, UK and Paul Weissenberg, European Commission.

HealthFest 2003 (Continued from Saturday, June 22)
National Mall between 3rd and 4th streets
10:00 a.m. to 3:00 p.m.

Global Health Media Brunch
Room 146A
11:30 a.m. to 1:30 p.m.
RSVP information to follow.
Up to 200 journalists may attend this event on biotechnology's potential for improving health in developing countries. Industry, government and thought leaders will discuss biotechnology applications that focus on the public health crisis in the developing world, and what the biotech industries can and are already doing to help. Genetically modified foods will be served. Speakers include: Pennsylvania Governor Edward G. Rendell, J.P. Garnier, Una S. Ryan and Florence Wambugu.

Bioethics Roundtable - Scientific Exploration: Should There Be Limits?
Room 146B/C
1:45 p.m. to 3:45 p.m.
Scientists, religious and secular ethicists, researchers, thought leaders and patients will discuss the social and ethical implications of scientific discovery and technological change. Panel includes: George Strait, Francis Collins, J. Craig Venter, Arthur Caplan, Simon Best, Linda Golodner, Kevin FitzGerald, Bob Edgars, Francis Fukuyama and Florence Wambugu.

Press Conferences

3:00 p.m.

Industry Canada "Spotlight on Biotechnology in Canada" Highlights on Canada's leadership in biotechnology; announcing new additions to science and technology infrastructure

Welcome Reception
Union Station, 50 Massachusetts Ave.
7:30 p.m. to 10:00 p.m.

Plenary Breakfast
Grand Ballroom
7:30 a.m. to 8:30 a.m.
Speakers include: NBA Player Jerry Stackhouse, BioGENEius Awards Winners, the National Biotechnology Teacher-Leaders Program and the Minority and Indigenous Fellows program.

BIO 2003 Lecture Series
Room 146C

8:45 a.m. to 9:15 a.m.
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases

9:30 a.m. to 10:00 a.m.
Professor Peter Doherty, Nobel Laureate

10:30 a.m. to 11 a.m.
Dr. Florence Wambugu, Kenyan plant geneticist and passionate advocate for the use of biotechnology in the developing world.

11:15 a.m. to 11:45 a.m.
Dr. Stephen Straus, director of the National Center for Complementary and Alternative Medicine

2:00 p.m. to 2:30 p.m.
Dr. William A. Haseltine, Chairman and CEO, Human Genome Science, Inc.

Press Conferences

9:00 a.m.

Biotechnology Industry Organization and Jerry Stackhouse Presentation of check to the Triple Threat Foundation

9:00 a.m

Exploria "Internet to Neuronet - Exploria Converges Design and Function with the Introduction of the Global Presentation System" Exploria will introduce the "Global Presentation System"; the first of its kind, secure, fully automated, on-line/off-line hybrid system for the deployment of high-end graphic presentations and other media to targeted audiences.

10:00 a.m.

Heller Ehrman To Be Announced

10:00 a.m.

Human Genome Sciences To Be Announced

11:00 a.m.

Helix BioMedix, Inc. "Peptides: Expanding Horizons" Announcement of breakthroughs in peptide production and the expansion of potential cosmetic and pharmaceutical applications that are likely to result.

11:00 a.m.

Government of Victoria - Melbourne, Australia "Victoria's Biotechnology Industry"

12:00 p.m.

Burrill & Company "Biotech: State of the Union Summer 2003" A mid-year analysis of the biotech industry as a follow-up to Burrill's seminal annual report.

1:00 p.m.

Crown Investments Corporation "Saskatchewan Biotech Success Stories and Future Prospects" Saskatchewan is gaining respect as a primary destination for bio-related industries.

2:00 p.m.

MdBio "MdBio Lab" Announcing the launch of MdBioLab- a mobile biotech lab initiative for the state of Maryland.

3:00 p.m.

Genencor To Be Announced

3:00 p.m.

New Economy Strategies, Inc. "CBC-AURP-NES Innovation Survey" The Council of Biotech Centers, the Association of University Research Parks - BIOPARKs and New Economy Strategies will announce the first-ever survey of more than 2500 individuals across the U.S. on the role of center and research parks as drivers of regional biotech and life science innovation.

4:00 p.m.

Queensland Trade and Investment Office Announcements of the latest achievements of Queensland's biotechnology industry.

BioJudiciary Roundtable
Room 146
3:30 p.m. to 5:30 p.m.
Legal and bioethics experts discuss the need for the biotechnology industry and its stakeholders to educate the courts, the media and the general public. Speakers include D.A. Henderson, M.D., M.P.H, Alan I. Leshner, Ph.D., Hon. Paul R. Michel, Joe Palca, Ph.D , G. Terry Sharrer, Ph.D, Hon. Randall R. Radat and Hon. James Rogan.

Exhibit Hall Ribbon-Cutting
Exhibit Hall Entrance
10:45 a.m.
Local and national officials cut the ribbon on the world's largest biotechnology exhibition - 325,000 square feet housing more than 1,400 displays from companies, organizations and governments around the world. Officials include Secretary Don Evans, Lord Sainsbury of Turville, and Minister Allan Rock.

Exhibit Hall Hours
11:00 a.m. to 5:00 p.m.

Plenary Luncheon
Grand Ballroom
12:15 p.m. to 1:45 p.m.
Speakers include Carl B. Feldbaum and FDA Commissioner Mark B. McClellan

Plenary Breakfast
Grand Ballroom
7:00 a.m. to 8:30 a.m.
Speakers TBA

BIO 2003 Lecture Series

Room 146C

4:00 p.m. to 4:30 p.m.
Dr. Francis Collins, director of the National Human Genome Research Institute

Press Conferences

9:00 a.m.

National Center for Food and Agricultural Policy (NCFAP) "Preliminary European Case Studies Launch" NCFAP will be releasing estimates of the benefits of agricultural biotechnology in Europe.

9:00 a.m.

Hill and Knowlton Australia "Technology Australia" Recent Australian technology breakthroughs of international interest

10:00 a.m.

NASA "NASA 101" Media Workshop

10:00 a.m.

University of Bern "Biotechnology and Biodiversity" A new report on global implications of biotechnology and biodiversity

11:00 a.m.

Lipomics "Lipomic Profiling and Drug Discovery" Announcement of recent advances in lipid analysis and interpretation that are leading to new understanding of metabolic disorders and individual response to treatment.

11:00 a.m.

Baxter Pharmaceutical Soulutions, LLC. Expansion announcement

1:00 p.m.

Biotechnology Industry Organization (BIO) Developments in industrial and environmental biotechnology in the United States and Europe

2:00 p.m.

I3C "An I3C Interoperable Solution" I3C members showcase an interoperability solution to help drive the progress of critically-needed open-source solutions in the life sciences

4:00 p.m.

Genentech, Inc. "The Next 30 Years in the War Against Cancer -- Were the successes of the late 1990s the beginning of a new frontier?"

4:00 p.m.

BayBio "Bay Area Biotech: Back to our Roots at BIO 2004" Highlighting BIO2004 in San Francisco and highlighting strengths of Bay area as a leader in biotechnology

Plenary Luncheon
Grand Ballroom
12:15 p.m. to 1:30 p.m.
Speakers TBA

Exhibit Hall/Regional Reception
Exhibit Hall A&B
4:30 p.m. to 6:30 p.m.

Gala Reception
International Trade Center (Ronald Reagan Building)
7:30 p.m. to 9:30 p.m.

Plenary Breakfast
Grand Ballroom
7:00 a.m. to 8:30 a.m.
Speakers include Sam Donaldson.

BIO 2003 Lecture Series

Room 144

11:15a.m. to 11:45 a.m.
Dr. John Gallin, director of the Warren Grant Magnuson Center for Research Resources

2:00 p.m. to 2:30 p.m.
Dr. Allen Spiegel, director of the National Institute of Diabetes and Digestive and Kidney Diseases

2:45 p.m. to 3:15 p.m.
Dr. Kenneth Olden, director of the National Institute of Environmental Health Sciences

3:30 p.m. to 4:00 p.m.
Dr. Robert Gallo, director of the Institute of Human Virology, University of Maryland- Baltimore

4:30 p.m. to 5:00 p.m.
Dr. Andrew von Eschenbach, director, National Cancer Institute, National Institutes of Health

Press Conferences

9:00 a.m.

Iowa Department of Economic Development "New Life Science Solutions for Success In Iowa" Major new initiatives and financial incentives will be introduced in this session. Specifics of recently passed legislation will illustrate how Iowa will continue to be a leader in new science discovery and delivery.

10:00 a.m.

Human Genome Sciences To Be Announced

10:00 a.m.

EuropaBio, DSM and Biotechnology Industry Organization (BIO) "A European Perspective on Industrial (White) Biotechnology" Developments in Europe relating to industrial (white) biotechnology

11:00 a.m.

Biotechnology Industry Organization (BIO) Joint initiative between BIO and International Council of Churches

12:00 p.m.

Sygenta "The Rice Genome - One Year Later"

Roundtable - Science and Faith: Introspection and Divergence
Room 144
8:45 a.m. to 10:45 a.m.
Religious leaders and theologians from a diverse set of faiths will discuss the promise and peril of science. Speakers include Hon. John Buchanan, Rabbi Hershel Billet, The Right Reverend Jane Holmes Dixon, Rev. Bob Edgar and Dr. Louay Safi.

FDA Roundtable
Room 202B
8:45 a.m. to 5:30 p.m.
Details TBA

Plenary Lunch
Grand Ballroom
12:15 p.m. to 1:45 p.m.
Actress Terri Garr

SARS: New Challenges, New Opportunities
Centers for Disease Control Panel
Room 207B
2:00 p.m. to 3:30 p.m.
Severe acute respiratory syndrome (SARS), the most recent example of new emerging diseases, has sickened thousands and killed hundreds in Asia and Canada. Its economic impact has been equally devastating to affected nations, and has had rippling effects around the world. During this session, we will provide a brief update on the global outbreak, summarize the tremendous scientific progress made in identifying and characterizing the SARS coronavirus, and explore challenges and opportunities for controlling this first major outbreak of the new century. Speakers TBA.

Exhibit Hall Break - Ice Cream Social
Exhibit Hall
2:15 p.m. to 3:15 p.m.

Closing Reception
Air & Space Museum at 6th Street and Independence Ave.
7:30 p.m. to 10:00 p.m.

If you're interested in:

BIO 2003 offers:

Biodefense Tracks Accessing Government Resources Biodefense Ethics Infectious Diseases

A new track on biodefense, with sessions on the potential uses of biotechnology to develop countermeasures against bioterrorism, policy changes needed to encourage such R&D, and existing programs within the Department of Homeland Security. Biodefense-related topics will also be discussed in the tracks on ethics, infectious diseases and accessing government resources.

Bioethics Events & Tracks Media Brunch BIO Roundtables Ethics Policy

Roundtables with bioethicisists and religious leaders on the social, ethical and spiritual implications of biotechnology. BIO 2003 will also feature a full track of bioethics sessions on issues such as stem cells and cloning, genetic-based testing and medicine, clinical trial reform and the ethical issues surrounding clinical trials of biodefense and trials in the developing world.

Business/Finance Events & Tracks Business Forum Accessing Government Resources Business Development 1 Business Development 2 Doing Business Globally Emerging Company Issues Finance Health Research Opportunity Forum Technology Transfer/Licensing

Sessions on business development, financing, industry trends in the U.S. and around the world, strategies for surviving the current capital crunch, accessing government resources, technology transfer and licensing, and creative partnering. BIO 2003 also will house a full Business Forum, where more than 200 companies will present business plans.

Careers/Employment Event Career Expo

The biotechnology industry's largest career fair, featuring sessions on opportunities and career trends in biotech. Upwards of 5,000 job applicants are expected to drop off resumes and CVs - and snag a little face time with HR decision-makers from industry-leading companies.

Drug Discovery & Development Events & Tracks Media Brunch Biodefense Cancer Drug Discovery and Development Ethics Genomics Health Research Opportunity Forum Infectious Diseases Manufacturing Neurobiology Nanotechnology Policy Regulatory Science

Tracks on drug discovery, cutting-edge science and technology, cancer and infectious disease, plus sessions on bioinformatics, biologics and manufacturing. From target identification to testing and launching a drug, BIO 2003 will cover every stage of the R&D process for new drugs and biologics. This year's convention also features several sessions and events on the need for new products for biodefense and diseases of the developing world.

Education Events & Tracks Education Initiatives HealthFest Communication

Sessions on the challenges of educating the public, media, lawmakers and legal professionals about biotechnology and its public policy implications. BIO 2003 will also feature the BioGENEius competition for middle-school science projects, and a three-day National Biotechnology Teacher-Leader program.

Economic Development Exhibit Hall Links Exhibitor Listings Pavilion Descriptions Exhibit Hall Regional Reception Events & Tracks Accessing Government Resources BioParks Centers and Research Parks Doing Business Globally Global Biotechnology Forum International Biotech Marketplace

News-making sessions where new data on the biotechnology industry's regional and global impact will be released, including the first-ever U.S. Department of Commerce survey of the entire U.S. industry. BIO 2003 also features an exhibit hall with more than 120 regions seeking to develop biotechnology as an economic development engine, plus sessions on strategies for building biotechnology parks and clusters, and efforts under way in Asia, Australia, Europe, and Latin America to develop biotechnology.

Environmental Issues Events & Tracks Global Biotechnology Forum Understanding Biotechnology Food and Agriculture Industrial and Environmental Manufacturing

Sessions on biotechnology's ability to contribute to sustainable development by boosting agricultural yields, reducing pesticide use and improving manufacturing processes.

Food & Agriculture Events & Tracks Media Brunch Newsmaker Session Global Biotechnology Forum Food and Agriculture Industrial and Environmental Manufacturing

Sessions on plant-made pharmaceuticals and other non-food applications of biotech-modified plants, functional foods, biotech as a tool for the developing world, the challenge of public acceptance, biodiversity, regulatory issues, animal biotechnology, and food labeling. A press briefing has been scheduled on the impact of the European moratorium on biotech crops, and the media brunch on Sunday, June 22, will cover how biotechnology can help improve nutrition and health in the developing world. BIO 2003 will provide comprehensive coverage of the impact of biotechnology on food and agriculture - the political issues, the evolving technologies, current trends and future projections.

Health/Global Health Events & Tracks HealthFest Media Brunch Health Research Opportunity Forum Global Biotechnology Forum Bioinformatics Biodefense Cancer Drug Discovery and Development Ethics Food and Agriculture Genomics Infectious Diseases Neurobiology Policy Regulatory Science

A two-day HealthFest on the National Mall designed to educate the public about how biotechnology is transforming medicine through new treatments, tests and preventive strategies, plus four days of convention tracks and sessions on such topics as cancer, infectious disease, clinical trials, trends in drug discovery and development, the potential health benefits of biotech foods in development, genetic testing and biotechnology's potential for treating diseases afflicting the developing world.

Health Policy/FDA/NIH Events & Tracks BIO 2003 Lecture Series FDA Roundtable Intellectual Property/Legal Manufacturing Policy Regulatory

Sessions on changes at the FDA, the scientific and policy challenges of follow-on biologics, European drug development policies, contract manufacturing strategies, the role of incentives in drug development, and the effects of patent law on biomedical innovation.

Industrial & Environmental Biotechnology Events & Tracks Global Biotechnology Forum Understanding Biotechnology Biodefense Industrial and Environmental Manufacturing Nanotechnology

Sessions on how biotechnology is transforming chemical manufacturing, energy production and environmental cleanup. Those who follow biotechnology are familiar with its impact on health-care and agriculture, but in the coming decades, biotech may transform industrial processes even more dramatically. The result? Industrial processes that are cleaner, more efficient, cheaper and in many cases all three.

Information Technology Tracks Bioinformatics Genomics

Sessions on how information technology and biology are converging to transform drug discovery and create information-based medicine.

Intellectual property and other legal issues Events & Tracks Biojudiciary Project Roundtable Business Development 2 Intellectual Property/Legal Policy Regulatory

A roundtable on the challenge of educating the legal profession and other stakeholders about the science, along with a dozen sessions covering intellectual property, the impact of accounting reform, new export controls, antitrust trends and the impact on biotechnology of other recent developments in the law.

International/Global Issues Events & Tracks Media Brunch (Details TBA) International Biotech Marketplace Global Biotechnology Forum Exhibit Hall Exhibit Hall Regional Reception Biodefense Centers and Research Parks Doing Business Globally Ethics Finance Food and Agriculture Intellectual Property/Legal

A media brunch session on how biotechnology is addressing the needs of the developing world, plus BIO's second-annual global forum, which will bring together leaders and policymakers to discuss initiatives to foster industry growth and utilization of the technology in both industrialized and developing nations. New data on the size and scope of the industry internationally will also be released, and several additional sessions will explore the challenges of developing biotech products in various regions of the world, including Europe, Asia, Latin America, and in the developing world.

Local/Regional Biotech Events & Tracks BioParks Exhibit Hall International Biotech Marketplace Exhibit Hall Regional Reception Global Biotechnology Forum Business Forum International Delegations Centers and Research Parks Doing Business Globally

Sessions at which regional data will be released on the impact and scope of the biotech industry in regions around the world. BIO 2003 also features a 350,000-square-foot exhibit hall with 1,400 displays from companies, economic development agencies and biotech associations. BIO 2003 also houses a full Business Forum, where more than 200 companies will present business plans.

Public Acceptance/ Biotech and the Media Events & Tracks Media Brunch Global Biotechnology Forum BIO Roundtables Understanding Biotechnology Communication Ethics Food and Agriculture Policy Regulatory

Sessions on current and future hot-button issues in agriculture, genetics and biodefense; efforts to overcome myths and barriers; and European attitudes about biotechnology. Media coverage, public knowledge and attitudes are important to the industry, ultimately determining the ability to raise capital, conduct sometimes controversial research and recoup large investments in innovation.

Religion and Faith Event BIO Roundtable

A roundtable bringing together religious leaders and theologians from a diverse set of faiths to discuss the promise and peril of science.

Science Events & Tracks Understanding Biotechnology Bioethics Roundtable Education Initiatives NIH Open House Biojudiciary Project Roundtable BIO 2003 Lecture Series Science and Faith Roundtable Accessing Government Resources Biodefense Bioinformatics Cancer Drug Discovery and Development Ethics Food and Agriculture Genomics Industrial and Environmental Infectious Diseases Nanotechnology Neurobiology Science Technology Transfer/Licensing

Several tracks on the cutting-edge science and technology that will transform our understanding of disease and ability to create new therapies. These sessions will take participants on a fantastic voyage into nanotechnology and the molecular realms of genomics and proteomics, while pointing toward the ultimate goal of synthesizing a tidal wave of information into a complete picture of how the human body works, including how we think and behave. In addition to a science track, BIO 2003 will feature special tracks on nanotechnology, neurobiology, genomics, cancer, infectious disease and drug discovery, as well as events on science education and communicating the reality of the science (vs. the myths) to the public, elected officials, the media and the legal profession.